The Department of Health and Human Services (HHS) released the 2014 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan on Tuesday.
HHS officials say national health security is bolstered by development of medical countermeasures, specifically with regard to emerging disease and biological attacks. The plan lays out blueprints for the PHEMCE to follow and ensures resources are being used efficiently to provide medical countermeasures to address infectious agents.
Within the plan, HHS provides funding estimates that would be needed from 2014-18 by the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the office of the Assistant Secretary for Preparedness and Response (ASPR). This funding would be used in countermeasure development and purchases.
Specific funding for the agencies breaks down as follows: $9.2 billion to the NIH and the National Institute of Allergies and Infectious Disease; $3.1 billion to the CDC and the Strategic National Stockpile; $5 billion to ASPR and the Biomedical Advanced Research and Development Authority; and $13.7 to the FDA. The report points out that these figures are budget submissions for 2017 and 2018 and do not consider other government funding priorities.